Cargando…
Novel Therapies for Follicular Lymphoma and Other Indolent Non-Hodgkin Lymphomas
When selecting therapy for patients with indolent non-Hodgkin lymphoma (iNHL) including follicular (FL), marginal zone (MZL), small lymphocytic (SLL), and lymphoplasmacytic lymphoma (LPL)/Waldenström macroglobulinemia (WM), there are several factors to consider. With a median age around 70 at diagno...
Autor principal: | Leslie, Lori A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8543415/ https://www.ncbi.nlm.nih.gov/pubmed/34694508 http://dx.doi.org/10.1007/s11864-021-00909-1 |
Ejemplares similares
-
The Future of Natural Killer Cell Immunotherapy for B Cell Non-Hodgkin Lymphoma (B Cell NHL)
por: Chu, Yaya, et al.
Publicado: (2022) -
Allogeneic Chimeric Antigen Receptor Therapy in Lymphoma
por: Khurana, Arushi, et al.
Publicado: (2022) -
Is There Still a Role for Transplant for Patients with Mantle Cell Lymphoma (MCL) in the Era of CAR-T Cell Therapy?
por: Beitinjaneh, Amer, et al.
Publicado: (2022) -
Follicular lymphoma
por: Leich, Ellen
Publicado: (2019) -
Follicular lymphoma genomics
por: Kumar, Emil, et al.
Publicado: (2019)